Department of Pathology, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525GA, Nijmegen, the Netherlands.
Radboud Institute for Molecular Life Sciences, Nijmegen, the Netherlands.
Virchows Arch. 2023 Jul;483(1):105-110. doi: 10.1007/s00428-022-03428-y. Epub 2022 Oct 14.
Clonality assessment by the detection of immunoglobulin (IG) gene rearrangements is an important method to determine whether two concurrent or subsequent lymphoid malignancies in one patient are clonally related. Here, we report the detailed clonality analysis in a patient with a diagnosis of B-cell acute lymphoblastic leukemia (B-ALL) followed by a histiocytic sarcoma (HS), in which we were able to study clonal evolution by applying next generation sequencing (NGS) to identify IG rearrangements and gene mutations. Using the sequence information of the NGS-based IG clonality analysis, multiple related subclones could be distinguished in the PAX5 P80R-mutated B-ALL. Notably, only one of these subclones evolved into HS after acquiring a RAF1 mutation. This case demonstrates that NGS-based IG clonality assessment and mutation analysis provide clear added value for clonal comparison and thereby improves clinicobiological understanding.
通过检测免疫球蛋白 (IG) 基因重排进行克隆性评估是确定一个患者中同时或随后发生的两种淋巴恶性肿瘤是否具有克隆相关性的重要方法。在这里,我们报告了一例 B 细胞急性淋巴细胞白血病 (B-ALL) 后继发组织细胞肉瘤 (HS) 患者的详细克隆性分析,我们通过应用下一代测序 (NGS) 来识别 IG 重排和基因突变,从而能够研究克隆进化。利用基于 NGS 的 IG 克隆性分析的序列信息,可以在 PAX5 P80R 突变的 B-ALL 中区分多个相关的亚克隆。值得注意的是,这些亚克隆中只有一个在获得 RAF1 突变后演变为 HS。该病例表明,基于 NGS 的 IG 克隆性评估和突变分析为克隆性比较提供了明确的附加价值,从而提高了临床生物学认识。